My progress in 2 months. Getting there! Progress Pictures 1/23/2025
The user experienced significant hair regrowth in two months using minoxidil foam and 0.5mg finasteride every other day, despite some side effects. They are considering adjusting the finasteride dosage and possibly adding biotin or dermarolling to their routine.
View this post in the Community →
Similar Community Posts Join
5 / 5 resultscommunity Fin + Minox for 11 months, new protocol - will update every 3 months
The user has been using finasteride and minoxidil for 11 months but experienced hair thinning after adding topical dutasteride. They plan to continue with Lipogaine, finasteride, and a reduced frequency of topical dutasteride, along with dermarolling and biotin.
community 50 years old 4.5 months on Fin
A 50-year-old user shared their positive experience with hair regrowth using finasteride, minoxidil, biotin, pumpkin seed oil, derma rolling, biotin shampoo, and Nizoral. They reported significant improvement in hair density and regrowth, especially in the crown and mid-scalp areas, with no side effects.
community 4 months, only Minoxidil 5% ,dermarolling twice a week. hair growth results. any suggestions?
Significant hair growth was achieved using Minoxidil 5% and dermarolling twice a week, with suggestions to add finasteride for maintenance. There is debate on when to apply Minoxidil after dermarolling to avoid irritation.
community Am I balding or is it just a mature/natural hairline?
The user is concerned about a receding hairline and is using finasteride, minoxidil, biotin, and derma rolling to address it. They are considering a hair transplant if these treatments don't work.
community First 2 months on oral fin and min.
A user shared progress pictures after two months of using oral finasteride and minoxidil, along with inconsistent derma rolling. Replies noted hairline improvement and good coverage, especially with afro hair.
Related Research
6 / 6 results
research Experimental and early investigational drugs for androgenetic alopecia
This review discusses current and emerging therapeutic strategies for androgenetic alopecia, noting limited evidence but suggesting areas such as prostaglandin analogs, PRP, and progenitor cell therapies as promising future directions.
research Clinical Efficacy of a Topical Compounded Formulation in Male Androgenetic Alopecia: Minoxidil 10%, Finasteride 0.1%, Biotin 0.2%, and Caffeine Citrate 0.05% Hydroalcoholic Solution.
This study found that a topical compounded formulation may improve hair density and general appearance in male patients with androgenetic alopecia after 6 months of use.
research Terapia Combinada no Tratamento Tópico da Alopecia Androgenética: Revisão Integrativa sobre Minoxidil, Finasterida, Fatores de Crescimento e os Fundamentos Científicos do Protocolo Vittahair
This study reviews existing literature on regenerative therapy for androgenetic alopecia, highlighting that integrating growth factors, biotin, D-pantenol, and other active ingredients using the Vittahair protocol may enhance hair follicle regeneration, increase hair density, and improve hair quality, providing a precise and evidence-based treatment alternative.
research Diffuse hair loss: Its triggers and management
This article reviews various causes of diffuse hair loss, highlighting the importance of identifying triggers through thorough examination for effective treatment and emphasizing patient education in management; it reports no new clinical findings.
research Platelet-Rich Plasma Therapy with Excelents Results in the Treatment of Post-Infectious Telogen Effluvium
This case study reported significant hair regrowth in a 67-year-old woman with telogen effluvium following SARS-CoV-2 infection after treatment with a combination of active agents, laser therapies, and medications.
research Controversy: is there a role for adjuvants in the management of male pattern hair loss?
This article reviews current hair loss treatments, proposing a hypothesis that a combination of drugs, supplements, and therapies may effectively manage hair loss, but presents no new clinical results.